You can follow the discussion on Members of FDA Advisory Committee Offer Perspectives on Flibanserin Approval in JAMA without having to leave a comment. Cool, huh? Just enter your email address in the form here below and you're all set.
You can follow the discussion on Members of FDA Advisory Committee Offer Perspectives on Flibanserin Approval in JAMA without having to leave a comment. Cool, huh? Just enter your email address in the form here below and you're all set.